Loading data for DSFIR.AS — first visit, this takes a few seconds.

DSM-Firmenich AG (DSFIR.AS)

Amsterdam: DSFIR.AS · 即時價格 · USD

95.50

-0.24 (-0.25%)

收盤價： Sep 02, 2026, 3:35 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

無可用資料

買價	n/a
市值	23.3B
營收 (ttm)	9.05B
淨利（ttm）	324M
	0.56
	1.4
	67.49
	23.05
P/B (ttm)	1.33
P/S (ttm)	2.57
財報日期	Feb 18, 2027

賣價	n/a
成交量	706,678
20 日平均成交量	840,113
開盤價	96.42
前收盤價	95.74
當日區間	94.96 - 96.64
52 週範圍	55.22 - 96.74
分析師	n/a
目標價	n/a
股利	$2.50 (2.62%)
除息日	May 11, 2026

關於 DSFIR.AS

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food ...

[閱讀更多]

產業 Specialty Chemicals

類股 Basic Materials

IPO 日期 Apr 18, 2023

員工 20,786

證券交易所 Amsterdam

股票代號 DSFIR.AS

網站 https://www.dsm-firmenich.com

完整的公司簡介

財務表現

DSM-Firmenich 在 2025 年的營收為 9.03B，較前一年的 9.05B 減少 -0.22%。淨利為 -1.08B，較前期減少 -532.4%。

EUR 中的財務資料財務報表

財報驚奇

DSM-Firmenich 已於 Invalid Date 公布季度財報：

營收為 n/a 低於預期 $0, 年增 NaN% 成長.
每股盈餘為低於預期 , 年增 NaN% 成長.

下次財報發布

DSM-Firmenich AG 的下次財報預計於 Feb 18, 2027, 盤中。
分析師預估營收 ... 升級

價格為何變動

新聞動態

1 週前 · Reuters

Exclusive-India investigates fragrance giants over price collusion, document shows

By Aditya Kalra NEW DELHI, Aug 25 (Reuters) - Global fragrance makers Givaudan, Firmenich and International Flavors & Fragrances face a second antitrust investigation by Indian authorities, according

3 週前 · WWD

Fine Fragrance’s Sweet Smell of Success Lasts

The recent spate of suppliers’ results shows the category remains robust.

2 月前 · The Wall Street Journal

Basic Materials Roundup: Market Talk

Find insight on European ingredients companies, Resolute Mining, Northern Star and more in the latest Market Talks covering Basic Materials.

3 月前 · Simply Wall St.

DSM-Firmenich Medisca Deal Highlights U.S. Vitamin API And Valuation Upside

DSM-Firmenich (ENXTAM:DSFIR) has partnered with Medisca to expand access to pharmaceutical-grade vitamin active pharmaceutical ingredients in the U.S. market. The agreement focuses on supplying Europe...

4 月前 · Simply Wall St.

Dividend Investors: Don't Be Too Quick To Buy DSM-Firmenich AG (AMS:DSFIR) For Its Upcoming Dividend

It looks like DSM-Firmenich AG ( AMS:DSFIR ) is about to go ex-dividend in the next 3 days. The ex-dividend date...

第 1 頁，共 2 頁

DSM-Firmenich AG (DSFIR.AS)